Risks of online advertisement of direct-to-consumer thermography for breast cancer screening.
Level V
Where this comes from
- Record sourced from PubMed, PMID 22216479.
- Also identified by DOI 10.1038/nrc3170.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Direct-to-consumer online advertising for thermography as a sole agent with which to diagnose breast cancer is misleading and exploits women who are seeking preventive health care for breast cancer. Regulatory action should be taken against companies who continue to mislead the public to ensure patient safety and evidence-based public health information.
Medical subject headings
- Advertising
- Breast Neoplasms
- Early Detection of Cancer
- Internet
- Thermography